SS
EBS icon

SBI Securities’s Emergent Biosolutions EBS Stock Holding History

SBI Securities’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41K Sell
4,942
-1,417
-22% -$14.7K ﹤0.01% 1177
2025
Q4 		$78.6K Sell
6,359
-145
-2% -$1.55K ﹤0.01% 924
2025
Q3 		$57.4K Sell
6,504
-6,459
-50% -$50.2K ﹤0.01% 1033
2025
Q2 		$82.7K Buy
12,963
+12
+0.1% +$69 ﹤0.01% 880
2025
Q1 		$62.9K Buy
12,951
+6,313
+95% +$52.3K ﹤0.01% 899
2024
Q4 		$63.5K Buy
+6,638
New +$60.9K ﹤0.01% 904

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SBI Securities's EBS Position: Q1 2026 in Review

SBI Securities reduced its Emergent Biosolutions (EBS) stake by 22% in Q1 2026, selling an estimated $14.7K and leaving 4,942 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

SBI Securities first reported a position in EBS in Q4 2024 and has held it in 6 quarters since. The position peaked at $82.7K in Q2 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • SBI Securities held 4,942 shares of Emergent Biosolutions worth $41K as of Q1 2026.
  • SBI Securities sold 1,417 Emergent Biosolutions shares in Q1 2026, an estimated $14.7K.
  • Emergent Biosolutions made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1177 holding.
  • SBI Securities first reported a position in Emergent Biosolutions in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Emergent Biosolutions position peaked at $82.7K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.